{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:20:35Z","timestamp":1766049635999,"version":"3.48.0"},"reference-count":28,"publisher":"Pensoft Publishers","issue":"6","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FM"],"abstract":"<jats:p>\n                    \ufeff\n                    <jats:bold>Abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Introduction<\/jats:bold>\n                    : Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by joint inflammation and significant extra-articular comorbidities. The autoimmune thyroid disease (AITD) is among the most frequent endocrine disorders associated with RA, reflecting potential shared immunopathogenic mechanisms.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Aim<\/jats:bold>\n                    : To evaluate the prevalence and clinical characteristics of thyroid dysfunction and autoimmunity in female patients with RA in comparison with a matched cohort of healthy controls and assess their association with disease activity and anti-cyclic citrullinated peptide antibodies (ACPA) positivity.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials and methods<\/jats:bold>\n                    : A cohort of 139 female RA patients was compared to 97 healthy controls. Thyroid function (TSH, fT4) and thyroid-specific antibodies (TPOAb, TgAb) were measured. RA disease activity was assessed using DAS28-ESR, with statistical analyses examining associations between thyroid pathology and RA features.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : The prevalence of thyroid dysfunction among RA patients was 40.2%, which was significantly higher than the 8.24% observed in controls (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt;0.001). Clinical hypothyroidism occurred more frequently in the RA group (20.86%). RA patients also had higher rates of TPOAb and TgAb positivity (37.28% and 30.5%, respectively) compared to controls. ACPA and TPOAb levels demonstrated a strong positive correlation (\n                    <jats:italic>r<\/jats:italic>\n                    =0.6375). Moreover, higher RA disease activity correlated with an increased prevalence of thyroid pathology.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    : Thyroid dysfunction and autoantibody positivity are significantly more prevalent in RA patients, suggesting shared autoimmune mechanisms. Routine thyroid function and antibody screening in RA management may facilitate early detection and improve outcomes.\n                  <\/jats:p>","DOI":"10.3897\/folmed.67.e165686","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:16:46Z","timestamp":1766049406000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical and immunological assessment of thyroid pathology in rheumatoid arthritis"],"prefix":"10.3897","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-2994","authenticated-orcid":true,"given":"Elena","family":"Deseatnicova","sequence":"first","affiliation":[{"name":"State University of Medicine and Pharmacy Nicolae Testemitanu in Chisinau, Chisinau, Moldova"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8957-8471","authenticated-orcid":true,"given":"Eugeniu","family":"Russu","sequence":"additional","affiliation":[{"name":"State University of Medicine and Pharmacy Nicolae Testemitanu in Chisinau, Chisinau, Moldova"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3278-436X","authenticated-orcid":true,"given":"Alexandru","family":"Corlateanu","sequence":"additional","affiliation":[{"name":"State University of Medicine and Pharmacy Nicolae Testemitanu in Chisinau, Chisinau, Moldova"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4856-867X","authenticated-orcid":true,"given":"Luana Andrea","family":"Macovei","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2077-8744","authenticated-orcid":true,"given":"Nistor","family":"Alesea","sequence":"additional","affiliation":[{"name":"State University of Medicine and Pharmacy Nicolae Testemitanu in Chisinau, Chisinau, Moldova"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3155-0422","authenticated-orcid":true,"given":"Lucia","family":"Andries","sequence":"additional","affiliation":[{"name":"State University of Medicine and Pharmacy Nicolae Testemitanu in Chisinau, Chisinau, Moldova"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8175-2583","authenticated-orcid":true,"given":"Elena","family":"Rezus","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3097-6181","authenticated-orcid":true,"given":"Liliana","family":"Groppa","sequence":"additional","affiliation":[{"name":"State University of Medicine and Pharmacy Nicolae Testemitanu in Chisinau, Chisinau, Moldova"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2258","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"165686_B1","doi-asserted-by":"crossref","unstructured":"1. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis and Rheumatism 2010; 62(9):2569\u201381.","DOI":"10.1002\/art.27584"},{"key":"165686_B2","doi-asserted-by":"crossref","unstructured":"2. Figus FA, Piga M, Azzolin I, et al. Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev 2021; 20(4):102776.","DOI":"10.1016\/j.autrev.2021.102776"},{"key":"165686_B3","doi-asserted-by":"crossref","unstructured":"3. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. The Lancet 2016; 388(10055):2023\u201338.","DOI":"10.1016\/S0140-6736(16)30173-8"},{"key":"165686_B4","doi-asserted-by":"crossref","unstructured":"4. Van Der Woude D, Van Der Helm-van Mil AHM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2018; 32(2):174\u201387.","DOI":"10.1016\/j.berh.2018.10.005"},{"key":"165686_B5","doi-asserted-by":"crossref","unstructured":"5. Gulati M, Farah Z, Mouyis M. Clinical features of rheumatoid arthritis. Medicine 2018; 46(4):211\u20135.","DOI":"10.1016\/j.mpmed.2018.01.008"},{"key":"165686_B6","doi-asserted-by":"crossref","unstructured":"6. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365(23):2205\u201319.","DOI":"10.1056\/NEJMra1004965"},{"key":"165686_B7","doi-asserted-by":"crossref","unstructured":"7. Prete M, Racanelli V, Digiglio L, et al. Extra-articular manifestations of rheumatoid arthritis: An update. Autoimmun Rev 2011; 11(2):123\u201331.","DOI":"10.1016\/j.autrev.2011.09.001"},{"key":"165686_B8","doi-asserted-by":"crossref","unstructured":"8. Cutolo M, Kitas GD, Van Riel PLCM. Burden of disease in treated rheumatoid arthritis patients: Going beyond the joint. Semin Arthritis Rheum 2014; 43(4):479\u201388.","DOI":"10.1016\/j.semarthrit.2013.08.004"},{"key":"165686_B9","doi-asserted-by":"crossref","unstructured":"9. Waldenlind K, Saevarsdottir S, Bengtsson C, et al. Risk of thyroxine-treated autoimmune thyroid disease associated with disease onset in patients with rheumatoid arthritis. JAMA Netw Open 2018; 1(6):e183567.","DOI":"10.1001\/jamanetworkopen.2018.3567"},{"key":"165686_B10","doi-asserted-by":"crossref","unstructured":"10. Ferrari SM, Fallahi P, Ruffilli I, et al. The association of other autoimmune diseases in patients with Graves\u2019 disease (with or without ophthalmopathy): Review of the literature and report of a large series. Autoimmun Rev 2019; 18(3):287\u201392.","DOI":"10.1016\/j.autrev.2018.10.001"},{"key":"165686_B11","doi-asserted-by":"crossref","unstructured":"11. McLeod DSA, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine 2012; 42(2):252\u201365.","DOI":"10.1007\/s12020-012-9703-2"},{"key":"165686_B12","doi-asserted-by":"crossref","unstructured":"12. Lichtiger A, Fadaei G, Tagoe CE. Autoimmune thyroid disease and rheumatoid arthritis: where the twain meet. Clin Rheumatol 2024; 43(3):895\u2013905.","DOI":"10.1007\/s10067-024-06888-6"},{"key":"165686_B13","doi-asserted-by":"crossref","unstructured":"13. Joshi P, Agarwal A, Vyas S, et al. Prevalence of hypothyroidism in rheumatoid arthritis and its correlation with disease activity. Trop Doct 2017; 47(1):6\u201310.","DOI":"10.1177\/0049475515627235"},{"key":"165686_B14","doi-asserted-by":"crossref","unstructured":"14. Prevoo MLL, Van\u2019t Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis: modified disease activity score. Arthritis Rheum 1995; 38(1):44\u20138.","DOI":"10.1002\/art.1780380107"},{"key":"165686_B15","doi-asserted-by":"crossref","unstructured":"15. Steinbrocker O. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140(8):659.","DOI":"10.1001\/jama.1949.02900430001001"},{"key":"165686_B16","doi-asserted-by":"crossref","unstructured":"16. Nazary K, Hussain N, Ojo RO, et al. Prevalence of thyroid dysfunction in newly diagnosed rheumatoid arthritis patients. Cureus [Internet] 2021 Sep 23 [cited 2025 Jul 12]; Available from: https:\/\/www.cureus.com\/articles\/71279-prevalence-of-thyroid-dysfunction-in-newly-diagnosed-rheumatoid-arthritis-patients","DOI":"10.7759\/cureus.18204"},{"key":"165686_B17","doi-asserted-by":"crossref","unstructured":"17. Liu YJ, Miao HB, Lin S, et al. Association between rheumatoid arthritis and thyroid dysfunction: A meta-analysis and systematic review. Front Endocrinol 2022; 13:1015516. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1015516\/full","DOI":"10.3389\/fendo.2022.1015516"},{"key":"165686_B18","doi-asserted-by":"crossref","unstructured":"18. Choy EHS, Panayi GS. Cytokine Pathways and joint inflammation in rheumatoid arthritis. Epstein FH, editor. N Engl J Med 2001; 344(12):907\u201316.","DOI":"10.1056\/NEJM200103223441207"},{"key":"165686_B19","doi-asserted-by":"crossref","unstructured":"19. Boelaert K, Newby PR, Simmonds MJ, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 2010; 123(2):183.e1\u2013183.e9.","DOI":"10.1016\/j.amjmed.2009.06.030"},{"key":"165686_B20","unstructured":"20. Frunze V, Deseatnicova E. [Thyroid gland pathology in rheumatoid arthritis]. Revista de \u015etiin\u0163e ale S\u0103n\u0103t\u0103\u0163ii din Moldova. 2021; 1(26):91\u20139. [Rumanian]"},{"key":"165686_B21","doi-asserted-by":"crossref","unstructured":"21. Atzeni F, Atzeni F, Doria A, et al. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: Prevalence and clinical value. Autoimmunity 2008; 41(1):111\u20135.","DOI":"10.1080\/08916930701620100"},{"key":"165686_B22","doi-asserted-by":"crossref","unstructured":"22. C\u00e1rdenas Rold\u00e1n J, Amaya-Amaya J, Castellanos-de La Hoz J, et al. Autoimmune thyroid disease in rheumatoid arthritis: a global perspective. Arthritis 2012; 2012:1\u201315.","DOI":"10.1155\/2012\/864907"},{"key":"165686_B23","doi-asserted-by":"crossref","unstructured":"23. Li L, Jiao F, Zhao J, et al. Risk factors of thyroid dysfunction in patients with rheumatoid arthritis. Cent Eur J Immunol 2024;49(2):126\u201331.","DOI":"10.5114\/ceji.2024.140634"},{"key":"165686_B24","doi-asserted-by":"crossref","unstructured":"24. Mahagna H, Caplan A, Watad A, et al. Rheumatoid arthritis and thyroid dysfunction: A cross-sectional study and a review of the literature. Best Pract Res Clin Rheumatol 2018; 32(5):683\u201391.","DOI":"10.1016\/j.berh.2019.01.021"},{"key":"165686_B25","doi-asserted-by":"crossref","unstructured":"25. Anoop J, Geetha F, Jyothi I, et al. Unravelling thyroid dysfunction in rheumatoid arthritis: History matters. Int J Rheum Dis 2018; 21(3):688\u201392.","DOI":"10.1111\/1756-185X.13040"},{"key":"165686_B26","doi-asserted-by":"crossref","unstructured":"26. Yavasoglu I, Senturk T, Coskun A, et al. Rheumatoid arthritis and anti-thyroid antibodies. Autoimmunity 2009; 42(2):168\u20139.","DOI":"10.1080\/08916930802428114"},{"key":"165686_B27","doi-asserted-by":"crossref","unstructured":"27. Shiroky JB, Cohen M, Ballachey ML, et al. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis 1993; 52(6):454\u20136.","DOI":"10.1136\/ard.52.6.454"},{"key":"165686_B28","doi-asserted-by":"crossref","unstructured":"28. Silman AJ, Ollier WER, Bubel MA. Autoimmune thyroid disease and thyroid autoantibodies in rheumatoid arthritis patients and their families. Rheumatology 1989; 28(1):18\u201321.","DOI":"10.1093\/rheumatology\/28.1.18"}],"container-title":["Folia Medica"],"original-title":[],"link":[{"URL":"https:\/\/foliamedica.bg\/article\/165686\/download\/pdf\/","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article\/165686\/download\/xml\/","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article_preview.php?id=165686&skip_redirect=1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:17:20Z","timestamp":1766049440000},"score":1,"resource":{"primary":{"URL":"https:\/\/foliamedica.bg\/article\/165686\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12,18]]}},"URL":"https:\/\/doi.org\/10.3897\/folmed.67.e165686","relation":{},"ISSN":["1314-2143","0204-8043"],"issn-type":[{"value":"1314-2143","type":"electronic"},{"value":"0204-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"e165686"}}